Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Articles
    4. NYSDOH guidance on material transaction law

      Articles

    Article

    NYSDOH guidance on material transaction law

    March 26, 2025

    LinkedInX (Twitter)EmailCopy URL

    By Jennifer Greco, Justin Pfeiffer, Scott Simpson, Laurie Cohen and Michele Masucci

    NYSDOH issues guidance on New York’s material transaction disclosure law, clarifying definitions, exemptions, and applicability.

    Nixon Peabody previously reported on the enactment of New York’s material transaction disclosure law (New York Public Health Law §§ 4550 et seq.) which went into effect on August 1, 2023, as well as proposed changes to New York’s material transaction disclosure law in Governor Hochul’s 2025–26 budget bill. Both reports highlighted uncertainty around the law, particularly with regard to the de minimis exception, which, if satisfied, exempts a transaction from disclosure.

    Just weeks before it is anticipated that New York’s budget legislation will be finalized, the New York State Department of Health (NYSDOH) has issued long-awaited guidance on the material transaction disclosure law, in the form of frequently asked questions (FAQs). Although the soon-to-be enacted budget legislation may require NYSDOH to revise its guidance, for now the FAQs clarify how NYSDOH interprets and intends to apply the current law:

    Definition of “Health Care Entity”

    • The statutory definition of “health care entity” (which expressly includes physician practices and groups) does not clearly apply to several types of health care providers that are not mentioned in the law.
    • NYSDOH indicates that it interprets the definition as including dental practices, clinical laboratories, pharmacies and wholesale pharmacies, independent practice associates (IPAs) and accountable care organizations (ACOs).
    • NYSDOH notes that its expanded interpretation of the term “health care entities” is not exhaustive.

    Out Of State Entities

    • NYSDOH will treat out-of-state entities as equally subject to the material transaction disclosure law.

    Definition of “Material Transactions”

    • NYSDOH interprets the term “material transaction” to include a contract for services commonly provided through a management or administrative services agreement.
    • This includes contracts for services with a management services organization (MSO) or similar services provider.

    Exemptions

    De Minimis Exemption

    • NYSDOH clarifies that, to determine whether a transaction satisfies the de minimis exception (a less than $25 million increase in gross in-state revenue), transaction parties must perform a 12-month lookback, which is measured from the anticipated closing date (the “lookback period”).
    • With a single transaction, the parties must assess and report transactions if the entity (or entities) to be acquired by, or merged into, a surviving entity will have $25 million or more of combined gross in-state revenue during the lookback period.
    • For situations involving a series of related transactions, the parties must assess the revenue associated with each related transaction that took place, or that will take place, during the lookback period. If the total combined gross in-state revenue for the transactions is $25 million or more, the series of transactions must be reported.

    Con/Insurance-Entity Exemption

    • Transactions subject to the certificate of need (CON) or insurance-entity approval process remain exempt from the material transaction disclosure law.
    • However, if portions of a transaction are not subject to such processes, they must be separately assessed to determine if the total in-state gross revenues from those portions of the transaction exceed the $25 million de minimis threshold.

    Good Faith Assessment

    Although NYSDOH has not yet released a form for submitting notices, the FAQs provide a non-exhaustive list of circumstances that parties should consider when conducting a good faith assessment of the anticipated impact of a transaction, including any:

    • Increase or reduction of services, locations, or contracts with insurance carriers;
    • Health care staffing changes;
    • Changes to amount of services provided to underserved populations; or
    • Expected increase in market consolidation.

    Nixon Peabody will continue to monitor and report on continuing developments related to this law and any impact the forthcoming budget bill may have.

    Locations

    RochesterLong IslandNew York CityAlbany

    Practices

    HealthcareHealthcare TransactionsHealthcare Regulatory & Compliance

    Industries

    Healthcare

    Insights And Happenings

    • Article

      OCR publishes fifth enforcement action under its Risk Analysis Initiative

      April 9, 2025
    • Article

      HHS is undergoing a major restructuring

      April 1, 2025
    • Alert

      Proposed California legislation expands scrutiny of health care transactions

      March 25, 2025
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved